Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr;45(2):67-68.
doi: 10.18773/austprescr.2022.021. Epub 2022 Mar 24.

Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

Ian D Coombes  1   2   3   4   5   6   7   8   9   10   11   12   13 , Amy Legg  1   2   3   4   5   6   7   8   9   10   11   12   13 , Tina Patterson  1   2   3   4   5   6   7   8   9   10   11   12   13 , Tanya Kelly  1   2   3   4   5   6   7   8   9   10   11   12   13 , Andrew Henderson  1   2   3   4   5   6   7   8   9   10   11   12   13 , Jason A Roberts  1   2   3   4   5   6   7   8   9   10   11   12   13
Affiliations
Editorial

Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

Ian D Coombes et al. Aust Prescr. 2022 Apr.
No abstract available

Keywords: COVID-19; SARS-CoV-2; molnupiravir; nirmatrelvir/ritonavir; quality use of medicines.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Andrew Henderson has participated in advisory board meetings for MSD. Jason A Roberts is on advisory boards for Pfizer, MSD and Gilead, and has received speaking fees from Gilead.

References

    1. Evans SJ, Jewell NP. Vaccine effectiveness studies in the field. N Engl J Med 2021;385:650-1. 10.1056/NEJMe2110605 - DOI - PMC - PubMed
    1. Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al.; EPIC-HR Investigators. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19 N Engl J Med 2022 [Epub 2022 Feb 16]. 10.1056/NEJMoa211854210.1056/NEJMoa2118542 - DOI - DOI - PMC - PubMed
    1. Plasencia-García BO, Rodríguez-Menéndez G, Rico-Rangel MI, Rubio-García A, Torelló-Iserte J, Crespo-Facorro B. Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review. Psychopharmacology (Berl) 2021;238:329-40. 10.1007/s00213-020-05716-4 - DOI - PMC - PubMed
    1. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al. MOVe-OUT Study Group . Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med 2022;386:509-20. 10.1056/NEJMoa2116044 - DOI - PMC - PubMed
    1. Kubler P. Fast-tracking of new drugs: getting the balance right. Aust Prescr 2018;41:98-9. 10.18773/austprescr.2018.032 - DOI - PMC - PubMed

Publication types

LinkOut - more resources